Host resistance directed selectively against h-2-deficient lymphoma variants: Analysis of the mechanism

Journal of Experimental Medicine

Volumn 162, Issue 6, 1985, Pages 1745-1759

  Ljunggren, Hans Gustaf ^a   Kärre, Klas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; BIOLOGICAL MODEL; CARCINOGENICITY; ETIOLOGY; H2 SYSTEM; HEREDITY; HOST RESISTANCE; IN VITRO STUDY; LYMPHATIC SYSTEM; LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMAL; ANTILYMPHOCYTE SERUM; CELL DIVISION; CELL LINE; CELL SURVIVAL; CLONE CELLS; COMPLEMENT; H-2 ANTIGENS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHOMA; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION CHIMERA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; VARIATION (GENETICS);

EID: 0022317963     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.162.6.1745     Document Type: Article

References (44)

1. Klein, J. 1981. Demystifying the major histocompatibility complex. Immunol. Today 2: 166.
2. Doherty, P. C., R. Korngold, D. H. Schwartz, andJ. R. Bennik. 1981. Development and loss of virus-specific thymic competence in bone marrow radiation chimeras and normal mice. Immunol. Rev. 58: 37.
3. Coligan, J. E., T. J. Kindt, H. Kehara, J. Martinko, and S. G. Nathensson. 1981. Primary structure of a murine transplantation antigen. Nature (Lond.). 291: 35.
4. Festenstein, H., and W. Schmidt. 1981. Variation in MHC antigenic profiles of tumor cells and its biological effects. Immunol. Rev. 60: 85.
5. DeBaetselier, P., S. Katzav, E. Gorelik, M. Feldman, and S. Segal. 1980. Differential expression of H-2 gene products in tumor cells in association with their metastatogenic properties. Nature (Lond.). 288: 179.
6. Katzav, S., P. DeBaetselier, B. Tartakovsky, M. Feldman, and S. Segal. 1983. Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: Association with shifts from nonmetastatic to metastatic cells. J. Natl. Cancer Inst. 71: 317.
7. Eisenbach, L., S. Segal, and M. Feldman. 1983. MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int. J. Cancer. 32: 113.
8. k. J. Immunol. 129: 1306.
9. Schrier, P. I., R. Bernards, R. T. M.J. Vaessen, A. Houweling, and A. J. van der Eb. 1983. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (Lond.). 305: 771.
10. Doherty, P., B. Knowles, and P. I. Wettstein. 1984. Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T-cell function. Adv. Cancer Res. 42: 1.
11. Finn, O. L., M. Lieberman, and H.S. Kaplan. 1978. H-2 antigen expression: loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line. lmmunogenetics. 7: 79.
12. Holtkamp, B., K. Fischer-Lindahl, M. Segal, and K. Rajewsky. 1979. Spontaneous loss and subsequent stimulation of H-2 expression in clones of a heterozygous lymphoma line. Immunogenetics 9: 405.
13. Jones, J. M., and J. D. Feldman. 1975. Alloantigen expression of a rat moloney sarcoma. J. Natl. Cancer Inst. 55: 995.
14. Cikes, M., S. Friberg, and G. Klein. 1973. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by moloney leukemia virus in cultured murine lymphomas. J. Natl. Cancer Inst. 50: 347.
15. Becker, S., R. Kiessling, N. Lee, and G. Klein. 1978. Modulation of sensitivity to natural killer cell lysis after in vitro explanation of mouse lymphoma. J. Natl. Cancer Inst. 61: 1495.
16. Haywood, G. R., and C. F. McKhann. 1971. Antigenic specificities on murine sarcoma cells: reciprocal relationship between normal transplantation antigens (H-2) and tumor specific immunogenicity. J. Exp. Med. 133: 1171.
17. Kfirre, K. 1985. Role of target histocompatibility antigens in regulation of natural killer activity: a reevaluation and a hypothesis. In Mechanisms of cytotoxicity by natural killer cells, R. B. Herberman and D. Callewaert, editors. Academic Press, New York. 91.
18. Ozato, K., and D. H. Sachs. 1981. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting of the H-2b haplotype reveal genetic control of isotype expression. J. Immunol. 126: 317.
19. 1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127: 34.
20. 125I-iododeoxyuridine. J. Natl. Cancer Inst. 43: 763.
21. Carlson, G. A., and T. G. Wegmann. 1977. Rapid in vivo destruction of semisyngeneic and allogeneic cells by nonimmunized mice as a consequence of nonidentity at H-2. J. lmmunol. 118: 2130.
22. Hũnig, T., and M.J. Bevan. 1980. Specificity of cytotoxic T cells from athymic mice. J. Exp. Med. 152: 688.
23. Wortis, H. H. 1974. Immunological studies of nude mice. Contemp. Top. Immunobiol. 3: 243.
24. Boon, T. 1983. Antigenic tumor cell variants obtained with mutagens. Adv. Cancer Res. 39: 121.
25. Frost, P., R. S. Kerbel, E. Bauer, R. Tartanella-Biondo, and W. Cefalu. 1983. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res. 43: 125.
26. Warner, N. L., M. F. Woodruff, and R. C. Burton. 1977. Inhibition of the growth of lymphoid tumors in syngeneic athymic (nude) mice. Int. J. Cancer. 20: 146.
27. Hochman, P. S., and G. Cudkowicz. 1979. Do natural killer cells engage in regulated reactions against self to ensure homeostasis? Immunol. Rev. 44: 13.
28. Habu, S., and K. Okumura. 1982. Cell lineage of NK cell: evidence for T cell lineage. In NK cells and other natural effector cells. R. B. Herberman, editor. Academic Press, New York. 209-214.
29. Snell, G. D., and L. C. Stevens. 1961. Histocompatibility genes of mice. III. H-1 and H-4 two histocompatibility loci in the first linkage group. Immunology. 4: 366.
30. Hellström, K. E., and I. Hellström. 1967. Allogeneic inhibition of transplanted tumor cells. Progr. Exp. Tumor Res. 9: 40.
31. 1 hybrid mice. J. Exp. Med. 134: 1513.
32. Carlson, G. A., D. Melnyachuc, and M.J. Melkor. 1980. H-2-associated resistance to leukemia transplantation: natural killing in vivo. Int. J. Cancer. 25:111.
33. Carlson, G. A., B. A. Taylor, S. T. Marshall, and A. H. Greenberg. 1984. A genetic analysis of natural resistance to nonsyngeneic cells: the role of H-2. Immunogenetics. 20: 287.
34. Klein, G. O., G. Klein, R. Kiessling, and K. Käirre. 1978. H-2-associated control of natural cytotoxicity and hybrid resistance against RBL-5. Immunogenetics. 6: 561.
35. Kfirre, K., G. O. Klein, R. Kiessling, S. Argov, and G. Klein. 1982. The beige model in studies of natural resistance to syngeneic, semisyngeneic, and primary tumors in NK cells and other effector cells. In NK cells and other natural effector cells. R. B. Herberman, editor. Academic Press, New York. 1369-1378.
36. Rolstad, B., and W. L. Ford. 1983. The rapid elimination of allogeneic lymphocytes:relationship to established mechanisms of immunity and lymphocyte traffic. Immunol. Rev. 73: 87.
37. Klein, E. 1971. Parental variants. Transplant. Proc. 3: 1167.
38. Hui, K., F. Grosveld, and H. Festenstein. 1984. Rejection of transplantable leukemia cells following MHC DNA-mediated cell transformation. Nature (Lond.). 311: 750.
39. Klein, G. O., K. Köirre, G. Klein, and R. Kiessling. 1980. The genetic regulation of NK activity: studies on congenic mice with B 10 or AKR background. J. Immunogenet. (Oxf). 7: 401.
40. Harmon, R. C., E. A. Clark, C. O’Toole, and L. S. Wixker. 1977. Resistance of H-2 heterozygous mice to parental tumors. I. Hybrid resistance and natural cytotoxicity to EL-4 are controlled by the H-2D Hh-1 region. Immunogenetics. 4: 601.
41. Wallich, R., N. Bulbuc, G. J. Hämmerling, S. Katzav, S, Segal, and M. Feldman. 1985. Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature (Lond.). 315:301.
42. Tanaka, K., K. J. Isselbacher, G. Khoury, and G. Jay. 1985. Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science (Wash. DC). 26: 228.
43. Zuniga, M. C., B. Malissen, M. McMillan, P. R. Brayton, S. S. Clark, J. Forman, and L. Hood. 1983. Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. Cell. 34: 535.
44. Evans, G. A., D. H. Margulies, B. Shykind, J. G. Seidman, and K. Ozato. 1982. Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature (Lond.). 300: 755.